MedWellAI Inc. MWAI
—
0.34
0.00
0.00%
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow MWAI
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| 35.89% | 42.51% | 52.51% | 69.86% |
+8 more TTM periods Free account |
|
| (208.51%) | (162.15%) | (152.63%) | (151.94%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
30.49% | 35.57% | 42.00% | 139.00% | |
Average Days of Receivables |
0.74 | 0.00 | 0.00 | 0.18 | |
Free Cash Flow per Share |
0.02 | (0.10) | (0.09) | 0.05 | |
Free Cash Flow |
0.11 | (0.64) | (0.54) | 0.31 | |
Capital Expenditures |
0.48 | — | 0.23 | 1.16 | |
Piotroski F-Score |
2.00 | 2.00 | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
41.61% | 98.26% | 226.70% | 43.87% | |
Accounts Receivable Turnover |
622.83 | 0.00 | 0.00 | 77.74 | |
Accounts Payable Turnover |
8.27 | 0.79 | 0.00 | 0.06 | |
Inventory Turnover |
0.00 | 0.00 | — | 0.00 | |
Average Days of Payables |
27.75 | 69.16 | 0.00 | 5,569.63 | |
Days of Inventory on Hand |
0.00 | 0.00 | — | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
119.94% | 226.74% | 391.17% | 440.44% | |
Share Based Compensation of Revenue |
10.88% | 59.35% | 94.07% | 100.81% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.16 | 0.24 | 0.25 | 0.24 | |
Depreciation/Fixed assets |
0.73 | 0.79 | 0.80 | 0.76 | |
Capex/Depreciation |
15.49 | 0.00 | 6.22 | 36.21 | |
Revenue per Share |
0.23 | 0.17 | 0.11 | 0.10 | |
Operating CF per Share |
(0.06) | (0.10) | (0.13) | (0.15) | |
Capex per Share |
0.08 | 0.00 | 0.04 | 0.20 | |
Capex to Sales |
(0.33) | 0.00 | (0.34) | (1.94) | |
Net Profit Margin |
(161.13%) | (242.59%) | (441.21%) | (606.54%) |
Columns are period end dates